Drug Profile
MBP 091
Alternative Names: MBP-091Latest Information Update: 12 Dec 2022
Price :
$50
*
At a glance
- Originator Vanderbilt University Medical Center
- Developer Mapp Biopharmaceutical; Vanderbilt University Medical Center
- Class Antivirals; Monoclonal antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Marburg virus disease